Findings

Congress finds the following: (1) A growing body of international medical guidance has advised against the routine use of puberty blockers, hormone therapy, and gender altering surgeries for minors, absent long-term evidence of benefit and safety. The rise in detransition and regret among young adults who underwent such procedures as minors further underscores the need for robust Federal safeguards. (2) The Federal Government has a compelling interest in protecting minors from experimental and irreversible medical procedures that may result in long-term harm, including sterilization, loss of sexual function, and psychological distress. (3) The transportation of minors across state lines to receive such procedures constitutes interstate activity subject to Federal regulation under the Commerce Clause of the United States Constitution.